MedElevator Войти в исследования
← Поиск публикаций

DOI 10.22074/cellj.2023.557550.1067

Медицинская библиотека · Cell journal · 2023

Advanced Therapy Medicinal Products in Vitiligo; Current Status, Future Prospect, and Approved Treatments.

Ghashghaei Shahriar, Abbaszadeh Mahkameh, Karimi Shahedeh, Ataie-Fashtami Leila, Bajouri Amir, Vosough Massoud

СтатьяПеревод пока не подготовлен

Аннотация

Vitiligo is an auto-immune disease, causing depigmentation of skin in 0.2-1.8% of global population. Topical corticosteroids and calcineurin inhibitors are the only treatments with firm evidence of optimal effectiveness with considerable side effects. Phototherapies might not induce serious side effects, although the effectiveness of the method is limited. Advanced therapy medicinal products (ATMPs) are emerging treatment modalities based on correction and replacement of affected genes, damaged tissues or cells in treatment of difficult-to-treat diseases. Due to optimal effectiveness and minimal side effects, ATMPs have recently gained much attention in order to develop new treatments. In this review, the ATMPs for treating vitiligo were along with its clinical success, affordability and cost-effectiveness. Currently, the main ATMP based products using in treatment of vitiligo are non-cultured epidermal cell, melanocytes, and hair follicle melanocytes. These products have shown promising results in the non-responding vitiligo patients. Furthermore, mesenchymal stem cells and multi-lineage differentiating stress enduring cells are other new potential modalities. Recently, Iranian Food and Drug Administration (IR-FDA) authorized the first cell-based product for vitiligo. This product is autologous suspension of keratinocytes and melanocytes. Although ATMPs are efficient and could be cost-effective in long term, the most important obstacle is affordability of them. This could be facilitated by insurance companies and instalments payment programs from manufacturers.

Для цитирования: Ghashghaei Shahriar, Abbaszadeh Mahkameh, Karimi Shahedeh, Ataie-Fashtami Leila, Bajouri Amir, Vosough Massoud. Advanced Therapy Medicinal Products in Vitiligo; Current Status, Future Prospect, and Approved Treatments.. Cell journal. 2023. DOI: 10.22074/cellj.2023.557550.1067.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.